Series B funding round for Silverback Therapeutics raising $79M in March 2020
Series B funding round for Silverback Therapeutics raising $79M in March 2020
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$201.5M
Top Valuation
-
Silverback Therapeutics raised $79M in a Series B round.
The round was announced on 03/01/20.
The round was led by U.S. Venture Partners.